Mark Van Buskirk Selected Research

Gastritis

12/2005

90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Van Buskirk Research Topics

Disease

5	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 12/2005
5	Neoplasm Metastasis (Metastasis) 12/2018 - 12/2005
5	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 11/2004
4	Neoplasms (Cancer) 12/2018 - 11/2004
2	Ascites 09/2011 - 12/2005
2	Liver Neoplasms (Liver Cancer) 09/2011 - 11/2004
1	Cystic Fibrosis (Mucoviscidosis) 04/2022
1	Adenocarcinoma 01/2017
1	Disease Progression 01/2016
1	Liver Failure 12/2005
1	Liver Diseases (Liver Disease) 12/2005
1	Pleural Effusion (Pleural Effusions) 12/2005
1	Gastritis 12/2005

Drug/Important Bio-Agent (IBA)

4	Yttrium-90IBA 01/2016 - 11/2004
3	SirtuinsIBA 12/2018 - 12/2014
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2018 - 12/2014
3	YttriumIBA 01/2017 - 02/2005
2	Fluorouracil (Carac)FDA LinkGeneric 12/2018 - 01/2016
2	Leucovorin (Folinic Acid)FDA Link 12/2018 - 01/2016
2	Bevacizumab (Avastin)FDA Link 01/2017 - 01/2016
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2011 - 11/2004
1	EnzymesIBA 04/2022
1	Carcinoembryonic AntigenIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	BilirubinIBA 09/2011
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2005

Therapy/Procedure

7	Microspheres (Microsphere) 01/2016 - 11/2004
4	Drug Therapy (Chemotherapy) 12/2018 - 12/2005
3	Radiotherapy 12/2018 - 12/2014
2	Therapeutics 01/2018 - 12/2005
1	Enteral Nutrition (Feeding, Tube) 04/2022
1	Combined Modality Therapy 01/2018
1	Aftercare (After-Treatment) 12/2005
1	Intra-Arterial Injections 02/2005